Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
“REACH offered a safe environment to learn and share in It was, and continues to be, a supportive, invigorating process! It was motivating and has increased my confidence in assessment, diagnosis of mental health cases in my day to day life and practice.”